Common Good Summit 2024

Laboratoires Pierre Fabre

Interview d'Eric Ducournau, Directeur Général du groupe Pierre Fabre


Pierre Fabre Laboratories is the world's 2nd largest dermo-cosmetics company and the 2nd largest private French pharmaceutical group. Its portfolio includes several medical franchises and international brands such as Pierre Fabre Oncologie, Pierre Fabre Dermatologie, Eau Thermale Avène, Ducray, Klorane, René Furterer, A-Derma, Même Cosmetics, Naturactive, Elgydium, Inava and Arthrodont. In 2023, Pierre Fabre Laboratories posted 2.83 billion euros in revenues, 70% of which came from international sales in 120 countries, and invested €190M in R&D, half of which in targeted oncology therapies. Historically based in the Occitanie region, and manufacturing over 95% of its products in France, Pierre Fabre Laboratories employs nearly 9,500 people worldwide. Pierre Fabre Laboratories is 86% owned by the Pierre Fabre Foundation, a recognized public interest foundation, and secondarily by its own employees through an employee stock ownership plan. Pierre Fabre Laboratories’ sustainability policy has been assessed by the independent AFNOR Certification body at the "Exemplary" level of its CSR label (ISO 26 000 standard for sustainable development). Further information about Pierre Fabre Laboratories can be found at, @PierreFabreGroup.

Our Interventions